Lockdowns and infections overshadow further positive vaccine news - a podcast by Phil Dobbie

Thursday 19th November 2020

Markets continue to be torn between the good news and the bad news. On the positive side, Pfizer is set to apply for emergency authorisation for its COVID-19 vaccine. NAB’s David de Garis says you’d have expected the news to have created more of a risk-on mood but, on the negative side, infection rates continue to rise. The spike in South Australia, with the six day statewide lockdown, has shown Australia is not immune. Beyond the virus, there’s hope that a UK-EU trade agreement will be announced next week, and the world is preparing for a different political outlook as the Biden administration gets set to move into the White House.

Further episodes of NAB Morning Call

Further podcasts by Phil Dobbie

Website of Phil Dobbie